Trade Inovio Pharmaceuticals Stock – Advancing DNA-Based Immunotherapies

Inovio Pharmaceuticals Inc. (NASDAQ: INO) is a biotechnology company developing DNA-based immunotherapies and vaccines targeting cancer and infectious diseases. Known for its innovative delivery platform, Inovio is advancing clinical trials across key indications. Listed under the symbol INO, it operates in the healthcare sector and attracts investors focused on early-stage biotech innovation.